Literature DB >> 18431669

Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.

H Yeşim Karasulu1, Z Evren Sanal, Sumru Sözer, Tamer Güneri, Gökhan Ertan.   

Abstract

The purpose of this research was to develop an emulsion formulation of indomethacin (IND) suitable for nasal delivery. IND was incorporated into the oil phases of oil in water (O/W) and water in oil (W/O) emulsions. For this purpose, different emulsifying agents (Tween 80, Span 80 and Brij 58) were used in two emulsion formulations. When the effects of several synthetic membranes (nylon, cellulose, cellulose nitrate) were compared with the sheep nasal mucosa, the cellulose membrane and sheep nasal mucosa showed similar permeation properties for O/W emulsion (P > 0.05). To examine the absorption characteristics of IND, the anti-inflammatory properties of intravenous solution of IND, intranasal O/W emulsions of IND (with or without enhancers) and intranasal solution of IND (IND-Sol) were investigated in rats with carrageenan-induced paw edema. When citric acid was added to the nasal emulsion, the anti-inflammatory activity was similar to that of intravenous solution (P > 0.05). Finally, it was concluded that, intranasal administration of IND emulsion with citric acid may be considered as an alternative to intravenous and per oral administrations of IND to overcome their adverse effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431669      PMCID: PMC2976954          DOI: 10.1208/s12249-008-9053-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

1.  Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.

Authors:  L Illum; A N Fisher; I Jabbal-Gill; S S Davis
Journal:  Int J Pharm       Date:  2001-07-03       Impact factor: 5.875

2.  Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy.

Authors:  Mohsen Tafaghodi; S Abolghasem Sajadi Tabassi; Mahmood-Reza Jaafari; S Rasoul Zakavi; Mahdi Momen-Nejad
Journal:  Int J Pharm       Date:  2004-08-06       Impact factor: 5.875

3.  Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits.

Authors:  M Ikechukwu Ugwoke; E Sam; G Van Den Mooter; N Verbeke; R Kinget
Journal:  Int J Pharm       Date:  1999-04-20       Impact factor: 5.875

4.  Permeation and pathways of human calcitonin (hCT) across excised bovine nasal mucosa.

Authors:  S Lang; B Rothen-Rutishauser; J C Perriard; M C Schmidt; H P Merkle
Journal:  Peptides       Date:  1998       Impact factor: 3.750

5.  Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.

Authors:  Prapasri Sinswat; Parkpoom Tengamnuay
Journal:  Int J Pharm       Date:  2003-05-12       Impact factor: 5.875

6.  Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization.

Authors:  Canan Hasçiçek; Nurşin Gönül; Nevin Erk
Journal:  Farmaco       Date:  2003-01

7.  Transdermal delivery of diclofenac sodium through rat skin from various formulations.

Authors:  Işik Sarigüllü Ozgüney; Hatice Yeşim Karasulu; Gülten Kantarci; Sumru Sözer; Tamer Güneri; Gökhan Ertan
Journal:  AAPS PharmSciTech       Date:  2006-10-20       Impact factor: 3.246

8.  Absorption of indomethacin from nasal cavity in rats.

Authors:  Z L Huang; M Kagoshima; E Kagawa; H Shimada
Journal:  Zhongguo Yao Li Xue Bao       Date:  1995-03

9.  In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives.

Authors:  Cetin Tas; Yalçin Ozkan; Ayhan Savaser; Tamer Baykara
Journal:  Farmaco       Date:  2003-08

10.  Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels.

Authors:  Jia-You Fang; Tsong-Long Hwang; Yann-Lii Leu
Journal:  Int J Pharm       Date:  2003-01-16       Impact factor: 5.875

View more
  2 in total

1.  Integration of PEG 400 into a self-nanoemulsifying drug delivery system improves drug loading capacity and nasal mucosa permeability and prolongs the survival of rats with malignant brain tumors.

Authors:  Yu-Shuan Chen; Yu-Han Chiu; Yuan-Sheng Li; En-Yi Lin; Dean-Kuo Hsieh; Chia-Hung Lee; Mao-Hsuan Huang; Hong-Meng Chuang; Shinn-Zong Lin; Horng-Jyh Harn; Tzyy-Wen Chiou
Journal:  Int J Nanomedicine       Date:  2019-05-16

2.  Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34).

Authors:  Dan Wang; Yimeng Du; Wenpeng Zhang; Xiaolu Han; Hui Zhang; Zengming Wang; Nan Liu; Meng Li; Xiang Gao; Xiaomei Zhuang; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.